Lamberts is a leading global nutritional supplement company.
With products that stand out for their safety and effectiveness,
it enhances daily health care.
When quality matters,
the choice is Lamberts.
EFFECTIVENESS
High-strength products based on sufficient and reliable scientific data.
The potency of our formulations is the result of 3 factors:
Preparation of products based on adequate and reliable scientific data
In the dietary supplement industry there is a huge number of formulations whose active ingredients are characterised by insufficient or negligible scientific background. The Lamberts® strategy, however, is to develop exclusively those products for which there is sufficient and reliable scientific data, as determined through published clinical studies.
Use of the appropriate pharmaceutical formulation that ensures optimal absorption and bioavailability
The absorption and bioavailability of the active ingredients is extremely important to achieve the desired biological action. At Lamberts® we select those pharmacotechnical forms (capsules, tablets, powder, oily suspension) that ensure maximum absorption and bioavailability for the active ingredient in question. All excipients are approved by the Pharmaceutical Society of Great Britain and meet European Pharmacopoeia standards.
SUSTAINABILITY
Sustainability, is the modern vision of Lamberts®, reflecting a production standard that ensures the best economic outcome for both people and the natural environment.
Sustainability, is the modern vision of Lamberts®, reflecting a production standard that ensures the best economic outcome for both people and the natural environment, for the present and for the future. This vision is becoming increasingly relevant because the healthcare industry is collectively the 13th largest producer of CO2 worldwide. But as many companies engage in greenwashing practices, it is important to extend our vision beyond superficial measures such as “glass packaging” by effectively addressing the causes associated with increased CO2 emissions.
For this reason Lamberts® is constantly looking for alternative active ingredients of plant origin which are identical in terms of bioequivalence to active ingredients of animal origin. A typical example is GlucosaGreen®, the first commercially available form of glucosamine sulphate, which is produced from non-GMO corn through a specialised and innovative fermentation process. This process ensures the production of glucosamine sulfate that is identical and bioequivalent to shellfish glucosamine sulfate. In addition, the whole production process is environmentally friendly as it requires less consumption of water and other raw materials and is accompanied by an overwhelmingly lower production of liquid and solid waste.
Safety
Ensuring the health of the consumer is our main priority. Raw materials, pharmaceutical manufacturing practice (GMP) and the choice of packaging guarantee the maximum safety of our products.
Ensuring the health of the consumer is our main priority. This is achieved by implementing 4 key steps in the manufacture of all our formulations.
Lamberts® raw materials purchasing managers have many years of experience in selecting reliable suppliers. The selected manufacturers are then subjected to continuous sampling and rigorous testing of their raw materials before they become Lamberts® suppliers. The raw materials used in the manufacture of all Lamberts® products:
– comply with the specifications used in pharmacopoeia
– concern substances intended for human clinical nutrition
– have not been irradiated as part of sterilisation.
CLINICAL STUDIES
Over the last 20 years we have invested over €2,000,000 in clinical nutrition studies, working jointly with many research departments of major Universities in the UK and Greece.
Lamberts® is one of the few, if not the only, clinical nutrition supplement company with such a programmed focus on clinical research . Over the last 20 years we have invested over €2,000,000 in clinical nutrition studies, working jointly with many research departments of major UK Universities to conduct studies in various areas of clinical practice, such as the use of magnesium in the treatment of asthma and the use of anthocyanidins in the treatment of fluid retention.
The emphasis on clinical research is also demonstrated by the fact that the company’s collaboration with University Clinics is not only limited to the UK borders, but extends to all countries where formulations are exported. In Greece, important studies have been carried out, such as the administration of selenium to sufferers of autoimmune thyroiditis, the administration of vitamin D to sufferers of metabolic syndrome, the administration of antioxidants to sufferers of idiopathic tinnitus, etc.